Con esta herramienta te facilitamos un acceso a todas las ofertas y demandas de tecnología europeas y a búsquedas de socios para participar en propuestas europeas de I+D publicadas en la red Enterprise Europe Network, pudiendo filtrar los resultados para facilitar las búsquedas más acordes con tus necesidades.

¿Quieres recibir estos listados de oportunidades de colaboración en tu correo de forma periódica y personalizada? Date de alta en nuestro Boletín

Para optimizar los resultados de la búsqueda, se recomienda utilizar términos en inglés.

Cooperación comercial para compañías farmacéuticas implicadas en oftalmología, tratamiento del glaucoma y enfermedades de la retina

Resumen

Tipo:
Oferta Tecnológica
Referencia:
TOIT20180711002
Publicado:
24/09/2018
Caducidad:
25/09/2019
Resumen:
Una empresa italiana fundada en 2009 ofrece una nueva tecnología patentada de rehabilitación visual mediante biorretroalimentación. La tecnología es objetiva, no invasiva, rápida y fácil de realizar y comprender por el paciente y el usuario, y actúa como un "electrocardiograma" del ojo para detectar enfermedades biofuncionales de las células mucho antes de que se produzcan cambios anatómicos. La empresa busca compañías farmacéuticas productoras de sustancias para el tratamiento y neuroprotección del glaucoma. El objetivo es establecer acuerdos comerciales con asistencia técnica para probar y hacer un seguimiento del tratamiento del paciente.

Details

Tittle:
Commercial partnership for Pharmaceutical companies involved in ophthalmology, glaucoma treatment and retinal diseases.
Summary:
The company, an Italian company founded in 2009, proposes an Innovative Patent technology for the visual rehabilitation by means of biofeedback. The company is searching for partners as pharmaceutical companies producing substances for glaucoma treatment and neuro-protection. The company objective is signing Commercial agreements with technical assistance, for testing and follow up of partners´ treatment
Description:
Company mission is to simplify the use of this important class of powerful diagnostic tools, often restricted to few specialists, and to make it smart and largely usable for the ophthalmologists and optometrists professionals.

The technology provides a test that is objective, non-invasive, fast, and easy to make and to understand by the patient and the user. The test is automatic, reliable, operator-independent, able to detect initial dysfunction of ganglion cells in Glaucoma patients before the occurrence of significant defects in the automated standard perimeter. The technology is adequate for monitoring of pharmacological treatment. This technology performs like an "electrocardiogram" of the eye that can detect bio-functional diseases of the cells much in advance than the anatomical changes occur.

The company is able to customize the system with different design and capabilities, based on a scientifically, widely recognized method.

The Company started with the commercialization of electrophysiology devices imported from one of the most important international brand in the field. Despite a recent brand, its R -Y- D engineers come with a long experience inherited by, one of the company early providing vision electrophysiology devices in the world since 1977.

In 2012, the company started developing his own line of a devices helping early glaucoma detection. Join with the device, the company has developed a software device that can run on the A10 hardware platform, intended for the visual rehabilitation by means of biofeedback. Most recently it has been developed a multifocal ERG system, a sophisticated diagnostic tool able to maps the retinal photoreceptors functionality.

The company are developing and improving a specific line of smart and easy devices for electrophysiology of vision, with other new features coming: with the aim to design and build complete workstations for visual electrophysiology .


Advantages and Innovations:
The Technology is an Innovative technology: proprietary video pattern generation method implemented by software and hardware for LCD, used in electrophysiology, that positively impacts on performance, costs and sizes. Easy and smart to use software conception
The Technology represents a partnership challenge for pharmaceutical companies who produce substances for glaucoma treatment willing to support professionals with: (1) an early diagnostic tool, (2) a "tester" for the effectiveness of specific medicines or supplements, and (3) a monitoring system the disease follow up. We are able to customize instruments with different design and capabilities, based on a scientifically, widely recognized method.
Stage of Development:
Available for demonstration
IPs:
Patents granted

Partner sought

Type and Role of Partner Sought:
Pharmaceutical companies who produce substances for glaucoma treatment and for other retinal diseases and who wish to aid field professionals customers with an early diagnostic tool that is a "tester" for the effectiveness of the the medicine or the supplements, and for monitoring the follow up of the disease.

Client

Type and Size of Client:
Industry SME <= 10
Already Engaged in Trans-National Cooperation:
No
Languages Spoken:
English
Italian

Keywords

Technology Keywords:
06001005 Diagnósticos, diagnosis
006001007 Diseases
006001012 Electromedical and Medical Equipment